Crescent Biopharma (CBIO) Net Margin (2013 - 2026)
Crescent Biopharma (CBIO) recorded Net Margin of -2240.90% in Q1 2026.
Powered by 
Analysis
Crescent Biopharma (CBIO) Net Margin (2013 - 2026) Analysis & Trends
For FY2025, Crescent Biopharma reported Net Margin of -1419.61%, up 2630.45 percentage points from FY2024.
- Annual Net Margin has a five-year change of -917.52 percentage points (FY2020 to FY2025).
- Across earlier years, Net Margin came in at -4050.06% in FY2024 (+364944.14 pp), -368994.20% in FY2023 (-306742.46 pp), -62251.74% in FY2022 (-56782.75 pp) and -5468.98% in FY2021 (-4966.89 pp).
- The Q1 2026 figure is the highest quarterly Net Margin since Q4 2023.
- Peak year-over-year performance for Net Margin in the last five years was a gain of 10122634.56 percentage points in Q2 2022, against a drop of 205933.48 percentage points in Q1 2022 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 26.44% |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 0.83% |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 24.24% |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 28.01% |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 22.65% |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 16.30% |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 37.28% |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 29.27% |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 19.55% |
| 10 | Crescent Biopharma | 418.60 Mn | -288.70 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -2,240.90% |
| Sep 30, 2024 | -5,324.26% |
| Jun 30, 2024 | -3,848.98% |
| Mar 31, 2024 | -2,837.69% |
| Dec 31, 2023 | -1,772.50% |
| Sep 30, 2023 | -1,506.19% |
| Jun 30, 2023 | -1,230.78% |
| Mar 31, 2023 | -1,780.97% |
| Jun 30, 2022 | -17,690.09% |
| Mar 31, 2022 | -207,285.91% |
| Dec 31, 2021 | -98,847.07% |
| Sep 30, 2021 | -20,023.48% |
| Jun 30, 2021 | -10,140,324.65% |
| Mar 31, 2021 | -1,352.43% |
| Dec 31, 2020 | -9,551.50% |
| Sep 30, 2020 | -1,372.25% |
| Mar 31, 2020 | -85.14% |
| Dec 31, 2019 | -2,418.94% |
| Dec 31, 2018 | -1,320.77% |
| Sep 30, 2016 | -42,457.80% |
API Access
Crescent Biopharma Net Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-margin&ticker=CBIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-margin", "ticker": "CBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-margin&ticker=CBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();